Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892358 · ClinicalTrials.gov registry record · NA
Preventing Bacterial and Viral Infections Among Injection Drug Users
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT01892358 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 252 participants.
The verdict
NCT01892358, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
We propose a randomized controlled trial (RCT) of the Skin intervention, compared to an assessment-only condition (both groups receive rapid HIV testing, a review of testing results, and brief HIV prevention counseling) among 350 injection drug users recruited during an acute medical hospitalization at Boston Medical Center. In the general hospital setting, injection drug users who otherwise might not seek care are accessible and teachable, and the presence of a drug-related illness can set the stage for patients to be more receptive to interventions2. We hypothesize that the Skin intervention will produce better outcomes at 1-, 3-, 6-, 9-, and 12-month(s) post-intervention.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL SKIN Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2013-09 |
| Est. Completion | 2020-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01892358
The ClinicalTrials.gov registry entry for NCT01892358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT01892358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01892358 about?
NCT01892358 is a clinical study titled "Preventing Bacterial and Viral Infections Among Injection Drug Users". We propose a randomized controlled trial (RCT) of the Skin intervention, compared to an assessment-only condition (both groups receive rapid HIV testing, a review of testing results, and brief HIV prevention counseling) among 350 injection drug users recruited during an acute medical hospitalization...
What is the current status of trial NCT01892358?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2013-09. Estimated completion is 2020-01.
What interventions are being tested in trial NCT01892358?
The interventions under investigation include: Treatment as Usual (OTHER), SKIN Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01892358?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.